Skip to Main Content

Smith & Nephew plc

SNN Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of SNN by members of U.S. Congress

Politician Type Traded
Lisa C. McClain House / R Sale $1,001 - $15,000 Jun 17, 2025
Lisa C. McClain House / R Purchase $1,001 - $15,000 Jun 09, 2025
Daniel S. Goldman House / D Sale $15,001 - $50,000 Jul 10, 2023
Michael T. McCaul House / R Sale $50,001 - $100,000 Sep 02, 2022
Michael T. McCaul House / R Sale $50,001 - $100,000 Sep 02, 2022
Michael T. McCaul House / R Sale $1,001 - $15,000 May 05, 2022
Michael T. McCaul House / R Sale $1,001 - $15,000 May 05, 2022
Michael T. McCaul House / R Sale $1,001 - $15,000 Jan 28, 2022
Michael T. McCaul House / R Sale $1,001 - $15,000 Jan 28, 2022
Michael T. McCaul House / R Sale $1,001 - $15,000 Dec 14, 2021
Michael T. McCaul House / R Sale $1,001 - $15,000 Dec 14, 2021
Michael T. McCaul House / R Purchase $15,001 - $50,000 Dec 03, 2021
Michael T. McCaul House / R Purchase $1,001 - $15,000 Dec 03, 2021
Michael T. McCaul House / R Purchase $15,001 - $50,000 Nov 16, 2021
Michael T. McCaul House / R Purchase $15,001 - $50,000 Nov 15, 2021
Michael T. McCaul House / R Purchase $1,001 - $15,000 Feb 26, 2021
Michael T. McCaul House / R Purchase $15,001 - $50,000 Feb 26, 2021
Michael T. McCaul House / R Purchase $15,001 - $50,000 Dec 28, 2020
Michael T. McCaul House / R Purchase $1,001 - $15,000 Dec 28, 2020
Michael T. McCaul House / R Sale $1,001 - $15,000 Dec 14, 2020
Michael T. McCaul House / R Sale $1,001 - $15,000 Dec 14, 2020
Michael T. McCaul House / R Sale $1,001 - $15,000 May 20, 2020
Michael T. McCaul House / R Sale $1,001 - $15,000 May 20, 2020
Michael T. McCaul House / R Sale $1,001 - $15,000 Jan 14, 2020
Michael T. McCaul House / R Sale $1,001 - $15,000 Jan 14, 2020
Michael T. McCaul House / R Purchase $1,001 - $15,000 May 07, 2019
Michael T. McCaul House / R Purchase $1,001 - $15,000 May 07, 2019
Dean Phillips House / D Sale $1,001 - $15,000 Apr 04, 2019
Thomas MacArthur House / R Purchase $1,001 - $15,000 Oct 17, 2018
Michael T. McCaul House / R Purchase $1,001 - $15,000 Jun 26, 2018
Michael T. McCaul House / R Purchase $15,001 - $50,000 Jun 26, 2018
Michael T. McCaul House / R Purchase $50,001 - $100,000 Apr 04, 2018
Michael T. McCaul House / R Purchase $50,001 - $100,000 Apr 04, 2018
Thomas MacArthur House / R Sale $1,001 - $15,000 May 01, 2017
Thomas MacArthur House / R Purchase $1,001 - $15,000 Jan 10, 2017
Thomas MacArthur House / R Purchase $15,001 - $50,000 Jan 09, 2017
Thomas MacArthur House / R Sale $15,001 - $50,000 Dec 07, 2016
Thomas MacArthur House / R Purchase $1,001 - $15,000 Sep 20, 2016
Thomas MacArthur House / R Purchase $15,001 - $50,000 Feb 22, 2016
Thomas MacArthur House / R Sale $50,001 - $100,000 May 27, 2015
Thomas MacArthur House / R Purchase $15,001 - $50,000 Mar 31, 2015
Thomas MacArthur House / R Purchase $15,001 - $50,000 Mar 25, 2015
SNN Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
SNN Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
SNN Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in SNN holdings by institutional investors

Quarterly net insider trading by SNN's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

  • $420,000 Apr 20, 2026 Issue: Medicare/Medicaid Taxation/Internal Revenue Code Trade (domestic/foreign) Defense
  • $340,000 Jan 20, 2026 Issue: Medicare/Medicaid Taxation/Internal Revenue Code Trade (domestic/foreign) Defense
  • $350,000 Oct 20, 2025 Issue: Trade (domestic/foreign) Defense Medicare/Medicaid Taxation/Internal Revenue Code Environment/Superfund
  • $370,000 Jul 21, 2025 Issue: Medicare/Medicaid Taxation/Internal Revenue Code Defense Environment/Superfund Trade (domestic/foreign)
  • $430,000 Apr 21, 2025 Issue: Defense Medicare/Medicaid Taxation/Internal Revenue Code Environment/Superfund Trade (domestic/foreign)
  • $430,000 Jan 15, 2025 Issue: Medicare/Medicaid Taxation/Internal Revenue Code Environment/Superfund Trade (domestic/foreign)
  • $440,000 Oct 21, 2024 Issue: Trade (domestic/foreign) Environment/Superfund Health Issues Taxation/Internal Revenue Code Medicare/Medicaid
  • $390,000 Jul 18, 2024 Issue: Budget/Appropriations Environment/Superfund Health Issues Taxation/Internal Revenue Code Medicare/Medicaid
  • $50,000 Jan 22, 2024 Issue: Medicare/Medicaid Health Issues
  • $410,000 Oct 18, 2023 Issue: Environment/Superfund Health Issues Taxation/Internal Revenue Code Medicare/Medicaid

SNN Estimated quarterly lobbying spending

SNN Revenue by Segment or Geography

By Segment
By Geography
SNN Income Statement
SNN Balance Sheet
SNN Cash Flow
U.S. Patents

New SNN patent grants

  • Patent Title: Orientated polymeric devices Sep. 19, 2017
  • Patent Title: Surgical guides Sep. 19, 2017
  • Patent Title: System and method for identifying a landmark Sep. 19, 2017
  • Patent Title: Antimicrobial biguanide metal complexes Sep. 05, 2017
  • Patent Title: Surface and image integration for model evaluation and landmark determination Aug. 29, 2017
  • Patent Title: Porous structure and methods of making same Aug. 29, 2017
  • Patent Title: Systems and methods for applying reduced pressure therapy Aug. 22, 2017
  • Patent Title: Anatomical motion hinged prosthesis Aug. 15, 2017
  • Patent Title: Fracture fixation systems Aug. 15, 2017
  • Patent Title: Alignment devices and methods Aug. 15, 2017
  • Patent Title: Methods and apparatus for performing knee arthroplasty Aug. 15, 2017
  • Patent Title: System for use in surgical procedures Aug. 15, 2017
  • Patent Title: Video endoscopic system Jul. 25, 2017
  • Patent Title: Pulsed current sintering for surfaces of medical implants Jul. 18, 2017
  • Patent Title: Orthopedic implant augments Jul. 18, 2017
  • Patent Title: High performance knee prosthesis Jul. 18, 2017
  • Patent Title: Implant components and methods Jul. 18, 2017
  • Patent Title: Wound management Jul. 04, 2017
  • Patent Title: Enzymatic wound debriding compositions with enhanced enzymatic activity Jul. 04, 2017
  • Patent Title: Orthopedic insert systems and methods Jul. 04, 2017
  • Patent Title: Hinged joint system Jul. 04, 2017
  • Patent Title: Femoral reaming system and method of performing trial reduction Jun. 27, 2017
  • Patent Title: Anchor assembly Jun. 27, 2017
  • Patent Title: Application of diffusion hardened material Jun. 20, 2017
  • Patent Title: Tissue graft fixation Jun. 20, 2017
  • Patent Title: Multiple portal guide Jun. 13, 2017
  • Patent Title: Method for creating a surgical resection plan for treating a pathological deformity of a bone Jun. 06, 2017
  • Patent Title: Orthopaedic implant system and fasteners for use therein Jun. 06, 2017
  • Patent Title: Porous implant structures Jun. 06, 2017
  • Patent Title: Medical device Jun. 06, 2017
  • Patent Title: Methods and apparatus for performing knee arthroplasty Jun. 06, 2017
  • Patent Title: Wound dressing and method of treatment May. 30, 2017
  • Patent Title: Orthopedic prosthesis with suture anchor features May. 30, 2017
  • Patent Title: Retrodrill system May. 30, 2017
  • Patent Title: Suture passer and method May. 30, 2017
  • Patent Title: Visualization guided acl localization system May. 23, 2017
  • Patent Title: Arthroscopic cutting blade May. 23, 2017
  • Patent Title: Cutting instrument May. 23, 2017
  • Patent Title: Distal femoral trial with removable cutting guide May. 16, 2017
  • Patent Title: Anchor May. 16, 2017
  • Patent Title: Knotless anchor May. 16, 2017
  • Patent Title: Portable wound therapy system May. 09, 2017
  • Patent Title: Silencer for vacuum system of a wound drainage apparatus May. 09, 2017
  • Patent Title: Apparatus for topical negative pressure therapy May. 09, 2017
  • Patent Title: Apparatuses and methods for negative pressure wound therapy May. 09, 2017
  • Patent Title: High flexion articular insert May. 09, 2017
  • Patent Title: Threaded suture anchor May. 09, 2017
  • Patent Title: Controller for an acoustic standing wave generation device in order to prevent clogging of a filter May. 02, 2017
  • Patent Title: Surgical fastening May. 02, 2017
  • Patent Title: Tissue-to-bone reattachment May. 02, 2017
Government Contracts

Federal grants, loans, and purchases

Government Contracts

Estimated quarterly amount awarded to SNN from public contracts

SNN News

Recent insights relating to SNN

CNBC Recommendations

Recent picks made for SNN stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in SNN

SNN Analyst Ratings

SNN Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
SNN Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $SNN stock a Buy, Sell, or Hold?

  • What is the price target for $SNN stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

SNN Top Shareholders
Shareholder
Shares Held
SNN Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $SNN stock?

  • Who owns the most shares of $SNN stock?

  • What funds own $SNN stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

SNN Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view SNN Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About SNN

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Smith & Nephew plc Executive Compensation
Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation